TERT and urinary bladder carcinoma: For example, urine ctDNA detection in bladder cancer has demonstrated high specificity (up to 100%) for TERT mutations, compared to plasma ctDNA, which has shown somewhat lower sensitivity in detecting bladder-specific mutation (Patel et al., 2017).